Novel transcript, antisense to UDP glycosyltransferase 8

This target is a long noncoding RNA (lncRNA) transcribed in the antisense orientation relative to the UDP glycosyltransferase 8 (UGT8) gene. Such antisense transcripts typically do not encode proteins but can play regulatory roles as a subset of lncRNAs. They may function by interfering with the transcription or stability of the sense (protein-coding) gene, recruiting chromatin-modifying complexes, or serving as microRNA sponges. Regulation of sense/antisense pairs may be part of epigenetic programming and cell type-specific gene expression. Although numerous antisense transcripts are annotated in the human genome and can be co-expressed with their corresponding sense gene, there is little evidence suggesting that this particular transcript is a direct disease or drug target. Instead, its biological significance lies in potential regulatory effects on UGT8, which itself is involved in sphingolipid metabolism in neural tissues. Key points: - The transcript is classified as a lncRNA, not a receptor, enzyme, transporter, or conventional pharmacological target. - The gene is accurately annotated, but may lack direct disease association or druggability. - No approved drugs or clinical biomarkers exist for this transcript. - Disease relevance, if any, is via UGT8 regulation, not direct involvement in pathogenesis or therapy. There is no misspelling or error in the target designation, but it is important to note its classification as a regulatory RNA, not a canonical therapeutic target.

Other names

ENSG00000297145antisense lncRNA to UGT8